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SelectAmino Acid IntricacyAs the central bridge connecting nutrient sensing and cellular
activities, mTORC1 has for years drawnmuch attention in the
cell metabolism field. Its frequent dysregulation in cancer and
the diverse therapeutic potential of the mTOR inhibitor rapa-
mycin have further spread its acclaim among cancer biolo-
gists, clinicians, and pharmaceutical companies. Although
efforts have yielded an in-depth understanding of the molec-
ular components that regulate mTORC1 localization and ac-
tivity at various steps along the signaling cascade, a key issue
that has not been adequately addressed is the amino acid
specificity in mTORC1 regulation. Does every flavor of amino
acid taste the same to mTORC1? If not, how are they distin-
guished, and perhaps more importantly, why does it matter?Amino Acid Sensing for mTORC1 Regulation. Courtesy of K.L. Guan.A recent study from the group of Kun-Liang Guan makes a
breakthrough in pursing this line of inquiry (Jewell et al.,
2015). RagA and RagB are well-characterized essential
regulators for the lysosomal recruitment and activation
of mTORC1. Surprisingly, instead of paralyzing the entire
mTORC1 pathway, they find that RagA/B deficiency in
mouse fibroblasts selectively impairs the ability of mTORC1
in sensing leucine and arginine, while its sensitivity to
glutamine remains intact. Together with an earlier work
from Michael Hall and colleagues in yeast (Stracka et al.,
2014), the findings highlight the mechanistic differences in
TORC1 activation upon stimulation of different amino acids.
Further investigation reveals the presence of an ADP ribosy-
lation factor 1 (Arf1)-dependent, Rag-independent pathway
for mTORC1 recruitment to the lysosome, suggesting a
context-specific role, rather than universal requirement, of
Rag in mTORC1 localization. Although this pathway appears
to be dedicated to glutamine-mediated mTORC1 regulation
and leads to distinct recruitment kinetics compared to its
Rag-dependent counterpart, the relative contribution of
these two pathways to mTORC1 activation in normal physio-
logical context remains to be determined. As Jewell et al.
(2015) mention in their paper, glutamine addiction is a feature
shared by a variety of cancer cells. Therefore, it would be
intriguing to explore whether this glutamine-specific sensing
mechanism would be particularly important in the cancersetting and to test its potential as a target for anti-cancer
therapeutic development.
The work in yeast and mouse fibroblasts reinforces the
notion that TORC1 does not see every amino acid in the
same way and suggests that the mechanisms behind this
may be evolutionary conserved. However, this leaves unre-
solved the identity of the direct amino acid sensor. Two
studies from Giulio Superti-Furga and David Sabatini repre-
sent the most recent progress toward this goal (Rebsamen
et al., 2015; Wang et al., 2015). The two groups indepen-
dently characterize a member of the solute carrier family
38, SLC38A9, as a lysosomal membrane-resident amino
acid transporter that is required for mTORC1 activation by
certain amino acids. The characterization of the amino acid
binding and transportation activity of SLC38A9 is exciting
and certainly in line with the putative role of SLC38A9 being
an amino acid sensor. However, fully supporting this notion
requires direct evidence linking amino acid binding and its
impact on signal transduction. Moreover, it appears that
SLC38A9 has a rather non-specific substrate profile. It is
therefore unclear whether, and if so to what extent,
SLC38A9 might be involved in differential mTORC1 regula-
tion by various amino acid inputs. In addition to lysosome
membrane-based sensors, the work from Jewell et al.
(2015) and others suggests that differential sensing occurs
even before mTORC1 recruitment to the lysosome. The
molecular basis for this early-stage sensing is yet another
open question. Indeed, as much as we have already known
about mTORC1 regulators, we are just getting started in
appreciating the mechanistic intricacy of the amino-acid-
sensing component of mTORC1 signaling.
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